JMP Securities Reaffirms Market Outperform Rating for Privia Health Group (NASDAQ:PRVA)

Privia Health Group (NASDAQ:PRVA)‘s stock had its “market outperform” rating reiterated by research analysts at JMP Securities in a research note issued on Friday,Benzinga reports. They currently have a $26.00 price objective on the stock. JMP Securities’ price target points to a potential upside of 3.01% from the stock’s current price.

PRVA has been the subject of several other research reports. Stephens reaffirmed an “overweight” rating and issued a $26.00 target price on shares of Privia Health Group in a research report on Thursday, January 2nd. Needham & Company LLC began coverage on shares of Privia Health Group in a report on Friday, January 10th. They set a “buy” rating and a $25.00 price target for the company. Macquarie started coverage on shares of Privia Health Group in a report on Monday, December 16th. They issued an “outperform” rating and a $25.00 price objective on the stock. Truist Financial boosted their target price on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Finally, Barclays boosted their price target on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, November 8th. Two equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Buy” and an average price target of $24.94.

Privia Health Group Trading Up 1.5 %

Shares of PRVA stock opened at $25.24 on Friday. The company’s fifty day simple moving average is $21.62 and its 200-day simple moving average is $20.23. Privia Health Group has a 52 week low of $15.92 and a 52 week high of $25.49. The company has a market cap of $3.03 billion, a PE ratio of 252.43, a P/E/G ratio of 3.07 and a beta of 0.87.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of PRVA. Riverbridge Partners LLC boosted its stake in shares of Privia Health Group by 19.7% during the 4th quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company’s stock worth $113,868,000 after acquiring an additional 958,418 shares in the last quarter. Eventide Asset Management LLC boosted its position in shares of Privia Health Group by 979.2% in the 3rd quarter. Eventide Asset Management LLC now owns 822,438 shares of the company’s stock valued at $14,977,000 after purchasing an additional 746,231 shares during the period. Loomis Sayles & Co. L P increased its stake in Privia Health Group by 55.0% in the 4th quarter. Loomis Sayles & Co. L P now owns 1,418,234 shares of the company’s stock worth $27,727,000 after purchasing an additional 503,002 shares in the last quarter. Icon Wealth Advisors LLC lifted its stake in Privia Health Group by 1,910.1% during the third quarter. Icon Wealth Advisors LLC now owns 300,889 shares of the company’s stock valued at $5,479,000 after buying an additional 285,920 shares in the last quarter. Finally, FMR LLC boosted its holdings in shares of Privia Health Group by 1.5% in the third quarter. FMR LLC now owns 18,169,043 shares of the company’s stock worth $330,858,000 after buying an additional 271,645 shares during the period. Institutional investors own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.